Alaunos Therapeutics's total assets for Q2 2024 were $4.68M, a decrease of -22.51% from the previous quarter. TCRT total liabilities were $907.00K for the fiscal quarter, a -26.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.